RxDoctor Payments Data

Richard Jones, DO

Family Medicine · Apple Valley, CANPI 1750388195

Payments from drug & device makers

$810in general payments, 2019–2025

Across 42 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$144
  • Johnson & Johnson$141
  • Pfizer$126
  • Lilly USA, LLC$83
  • GSK$65
  • Merck$61
  • plus $190 from 8 others

What the payments were for

  • Food & beverage$810100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$810 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$33,157
Medicare patients
172
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$82,881
DovatoDolutegravir Sodium/Lamivudine13$37,728
EliquisApixaban31$23,626
JardianceEmpagliflozin18$20,522
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,318
TrulicityDulaglutide15$14,662
FarxigaDapagliflozin Propanediol16$11,489
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$7,161
Aripiprazole11$5,428
Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm25$4,591
Albuterol Sulfate HfaAlbuterol Sulfate93$3,516
PremarinEstrogens, Conjugated16$3,480
Atorvastatin Calcium326$2,693
Gabapentin101$2,615
Levothyroxine Sodium128$2,492

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$30$82,88187 claims
Boehringer IngelheimJardiance, Stiolto Respimat$33$27,68331 claims
PfizerEliquis, Premarin$126$27,10747 claims
GSKTrelegy Ellipta$65$15,31817 claims
Lilly USA, LLCTrulicity$83$14,66215 claims
AstraZenecaFarxiga$18$11,48916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Apple Valley

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →